Chronic Graft Versus Host Disease (cGvHD)Symptoms, Doctors, Treatments, Advances & More
Chronic Graft Versus Host Disease (cGvHD) Overview
Learn About Chronic Graft Versus Host Disease (cGvHD)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Ryotaro Nakamura, M.D.
Ryotaro Nakamura is an Oncologist practicing medicine in Duarte, California. Dr. Nakamura is rated as an Elite provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Colonoscopy.
City Of Hope Comprehensive Cancer Center-Duarte
Badri Modi is a Dermatologist practicing medicine in Duarte, California. Dr. Modi is rated as a Distinguished provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Melanoma, Actinic Keratosis, and Bone Graft. Dr. Modi is currently accepting new patients.
Dept Of Transfusion Medicine/Nih Clinical Center
Steven Pavletic is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Pavletic is rated as an Elite provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft.
Background: * Chronic graft-versus-host disease (cGVHD) is a multi-organ alloimmune and autoimmune disorder that occurs following allogeneic hematopoietic stem cell transplantation (alloHSCT). It is characterized by immune dysregulation, immunodeficiency, impaired organ function, and decreased survival. * Each year about 8000 patients receive allogeneic hematopoietic stem cell transplant (alloHSCT) in North A...
Summary: This study is a multicenter, prospective, observational cohort study designed to enroll a total of 340 patients undergoing allogeneic hematopoietic stem cell transplantation. Through comprehensive evaluations by hematology departments, ophthalmology departments, and patient-reported outcomes, the study aims to assess patient-reported outcomes, overall incidence, risk factors, and other clinical ou...
